{
    "nctId": "NCT06580743",
    "briefTitle": "Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer",
    "officialTitle": "Efficacy Verification in Early Diagnosis and Management of Lymphedema Through Home Body Water Analyzer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 80,
    "primaryOutcomeMeasure": "Measurement of impedances and extracellular water (ECW) ratio",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults 18 and over who are diagnosed with unilateral breast cancer.\n* Unilateral lumpectomy, unilateral mastectomy, or simultaneous contralateral prophylatic mastectomy within 12 months of enrollment\n* Axillary lymph node dissection or sentinel node biopsy within 12 months of enrollment\n* Adjuvant or neoadjuvant chemotherapy and/or radiation therapy are allowed\n* Breast cancer reconstruction completed or planned is allowed\n* Study participants must own or have access to a smartphone, iPhone (IOS version 9.0 or above) or Android phone (Android 8.1 or above).\n\nExclusion Criteria:\n\n* Bilateral breast cancer\n* Previous history of breast cancer prior to current diagnosis.\n* Existing diagnosis of lymphedema at the time of enrollment\n* Cellulitis or other active infection at the time of enrollment\n* Adults who are unable to consent.\n* Pregnant women\n* Prisoners\n* Individuals under the age of 18 years old\n* Individuals who are illiterate\n* Individuals who lack the capacity to consent\n* Non-English speakers\n* Individuals with medical implant devices such as pacemakers, or essential support devices such as patient monitoring systems.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}